Stock Fundamentals

Company Information

Company Name
Fate Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US31189P1021
CIK: 0001434316
CUSIP: 31189P102
Currency: USD
Full Time Employees: 161
Phone: 858 875 1800
Fiscal Year End: December
IPO Date: Oct 01, 2013
Description:

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.

Address:

12278 Scripps Summit Drive, San Diego, CA, United States, 92131

Directors & Officers

Name Title Year Born
Dr. Bahram Valamehr M.B.A., Ph.D. President, CEO & Director 1977
Mr. Kamal Adawi M.S., MBA CFO & Treasurer 1979
Ms. Cindy R. Tahl J.D. Chief Legal & Compliance Officer and Corporate Secretary 1973
Ms. Jessica Francis Senior Vice President of Human Resources & Operations NA
Dr. Martin Hosking Head of Research NA
Dr. Tunde Babalola Ph.D. Senior Vice President of Technical Operations & Quality NA
Mr. Ryan Douglas Senior Director of Investor Relations & Business Development NA
Mr. Andrew Henry Senior Vice President of Clinical Operations 1964
Dr. Yu Cai J.D., Ph.D. Head of Intellectual Property & Assistant General Counsel NA
Ms. Kate Duvall Corporate Controller NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 09, 2026 Bahram Valamehr N/A Sale 5.19K $1.07 $5.55K
Jan 09, 2026 Cindy Tahl N/A Sale 10.59K $1.06 $11.22K
Aug 04, 2025 Bahram Valamehr N/A Sale 14.47K $1.06 $15.33K
Aug 04, 2025 Cindy Tahl N/A Sale 9.04K $1.06 $9.58K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Redmile Group, LLC 12.87M Mar 31, 2026 11.04% $1.02 0.00%
BlackRock Inc 10.07M Mar 31, 2026 8.64% $0.00 -1.06%
Vanguard Group Inc 8.97M Dec 31, 2025 7.70% $0.00 1.96%
Vanguard Capital Management, LLC 4.19M Mar 31, 2026 3.60% $0.00 0.00%
Vanguard Portfolio Management, LLC 4.13M Mar 31, 2026 3.55% $0.00 0.00%
Acadian Asset Management LLC 4.12M Mar 31, 2026 3.53% $0.01 44,203.23%
Two Sigma Investments LLC 3.47M Mar 31, 2026 2.97% $0.00 99.92%
Johnson & Johnson 3.38M Mar 31, 2026 2.90% $0.62 0.00%
AQR Capital Management LLC 3.00M Mar 31, 2026 2.58% $0.00 158.31%
Renaissance Technologies Corp 2.97M Mar 31, 2026 2.55% $0.01 26.00%
Geode Capital Management, LLC 2.59M Mar 31, 2026 2.22% $0.00 4.95%
State Street Corp 2.26M Mar 31, 2026 1.94% $0.00 -0.09%
UBS Group AG 1.82M Mar 31, 2026 1.56% $0.00 351.45%
Two Sigma Advisers, LLC 1.65M Dec 31, 2025 1.42% $0.00 63.96%
The Goldman Sachs Group Inc 1.33M Mar 31, 2026 1.14% $0.00 -7.48%
TANG CAPITAL MANAGEMENT LLC 1.17M Mar 31, 2026 1.00% $0.07 0.00%
Citadel Advisors Llc 942.93K Mar 31, 2026 0.81% $0.00 25.83%
Dimensional Fund Advisors, Inc. 883.79K Mar 31, 2026 0.76% $0.00 -43.97%
Irenic Capital Management LP 878.06K Mar 31, 2026 0.75% $0.07 0.00%
Northern Trust Corp 811.92K Mar 31, 2026 0.70% $0.00 10.82%

Shares Statistics

Shares Outstanding: 116.56M
Shares Float: 101.86M
% Insiders: 116.60%
% Institutions: 7,299.50%
Short % Float: 7.23%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 2.97M 2.55% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 2.59M 2.22% ▲ 0.93% May 29, 2026
3 Vanguard Strategic Equity Inv 2.54M 2.18% ▲ 0.00% Mar 31, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 1.18M 1.01% ▲ 6.87% Apr 30, 2026
5 Fidelity Small Cap Index 1.08M 0.93% ▲ 0.97% Mar 31, 2026
6 iShares Russell 2000 Value ETF 911.21K 0.78% ▲ 0.00% May 29, 2026
7 BlackRock Advantage Small Cap Core Instl 876.11K 0.75% ▲ 0.00% Apr 30, 2026
8 Bruce 789.19K 0.68% ▲ 8.23% Mar 31, 2026
9 Russell 2000 Equity Index Fund B 758.23K 0.65% ▼ 0.05% Dec 31, 2025
10 State St Russell Sm/Mid Cp® Indx SL Cl I 638.96K 0.55% ▲ 0.00% May 31, 2026

Valuation Metrics

Enterprise Value: $263.30M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $361.33M
EBITDA: $-125.84M
PEG Ratio: $0.00
Book Value: $1.55
Earnings/Share: $-1.09
Profit Margin: 0.00%
Operating Margin: -2,540.42%
ROA (TTM): -25.29%
ROE (TTM): -55.50%
Revenue (TTM): $6.32M
Revenue/Share (TTM): $0.05
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -20.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.79x 0.02x 0.35x N/A -0.04x
2024-12-31 7.58x 0.02x 0.28x N/A -0.04x
2023-12-31 8.48x 0.02x 0.27x N/A -0.04x
2022-12-31 4.40x 0.01x 0.31x -52.79x -0.02x
2021-12-31 7.79x 0.01x 0.26x -47.79x -0.03x
2020-12-31 5.78x 0.01x 0.38x -53.37x -0.03x
2019-12-31 8.17x 0.01x 0.19x -57.49x -0.02x
2018-12-31 7.53x 0.09x 0.25x -39.56x -0.23x
2017-12-31 9.29x 0.29x 0.27x -33.22x -0.54x
2016-12-31 6.14x 0.15x 0.23x -19.53x -0.35x
2015-12-31 4.88x 0.45x 0.44x -12.51x -0.64x
2014-12-31 10.89x 0.69x 0.45x -45.36x -0.80x
2013-12-31 11.88x 0.03x 0.09x -22.20x -0.09x
2012-12-31 2.02x -0.07x 5.77x -27.84x -0.28x
2011-12-31 1.82x -0.10x 7.45x -104.67x -0.38x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FATE.US!